[Other] In adults with overweight or obesity, weekly subcutaneous cagrilintide–semaglutide increased weight loss at 68 wk

ahmeddiaaaa Post time The day before yesterday 13:32 | Show all posts |Read mode

This post will be closed automatically in 2026-07-28 13:32

Reward20points

journal：Annals of Internal Medicine

Authors：Arnav Agarwal; Raj Padwal;

Published date：2025-10-

DOI：10.7326/annals-25-03745-jc

PDF link：https://www.acpjournals.org/doi/pdf/10.7326/ANNALS-25-03745-JC

Article link：https://doi.org/10.7326/annals-25-03745-jc

Article Source：American College of Physicians。

Remark：

Reply

All Reply0 Show all posts

ahmeddiaaaa Lv.3

Intermediate member

[Other] In adults with overweight or obesity, weekly subcutaneous cagrilintide–semaglutide increased weight loss at 68 wk Copy